Those who practice medicine in the United States are unavoidably confronted by the fact that health status, disease burden and lifespan vary by population groups -particularly the persistent reality that cardiovascular disease outcomes are poorer in African Americans compared to European Americans (the majority reference group), Asian Americans (those from China and Japan having best outcomes, those from South Asia having higher disease burden at younger ages) and Hispanic Americans (who experience better than expected outcomes despite having many risk factors). The causes for population variation in health outcomes are multifactorial and can include biologic, environmental (physical and social), genetic, epigenetic and social determinants, a mixture of disparities and differences.
In this issue of Circulation, Kilic et al 1 features and one year post-transplant mortality using data from nearly 19,000 patients who have un nde de derg rg rgo on one e e or or o t thot ot tro ro ropi p c heart transplantation in the he he U U United States ov ov ver a a 1 1 10 0 year period. They co om mp mpared clini nica ca al ch h ha ar arac ac cte te ter ri rist st sti ic ics, s, i i imm mm mmu un nolo og ogi ical fe e eatu u ure re es s a an and d on on ne e-ye yea ar r p p pos os st t t-t tr tran ans sp spla la lant nt t o o out u utc co om m mes am m mon on ong g g th thre re ee e e U US US ra ac acia ial l/e et ethn hnic ic c g gro ro roup up ups s d de desi si sign gn gnat ated ed ed a a as b bla a ack ck k ( ( (Af Af Afri ri rica ca an n Am Am A er eri ic ican an n), ), ) w w whi hi hite te te a an nd nd Hispanic. Sign gn gnif if fic ic can an ant t di di diff f er er ren en ence ce es s s we we were r i i ide de dent nt ntif if fie ie ied d in in n o o one ne-y -y yea ea ear r r po po post st s t tra ra rans ns nspl pl plan an ant t t mo mo mort rt rtal al alit it ity y y and in transplant mortality for African Americans compared to whites and Hispanics. Much of their analysis focused on the relationship between the performance status of the transplant center and the one year post-transplant mortality outcomes by race/ethnicity with the following principal findings: Firstly, African Americans were more likely to undergo transplantation at poorer performing centers; secondly, at those centers, African Americans had significantly increased risk adjusted mortality; thirdly, centers with worse performance status had higher proportions of African American patients than whites and Hispanics. However, the most interesting, unexpected and compelling finding in the study was that African Americans transplanted at excellently performing centers also had increased one year post-transplant mortality compared to whites (OR 1.42, 95% CI 0.99-2.02, p=0.06). It is startling that the ratio of mortality between whites
and African Americans at excellently performing centers was worse (0.72) than at poorly performing centers (0.83) (p=0.03 for the difference in 1 year mortality between races at excellent centers, Table 3 ). They correctly identify the limitations of analysis of limited registry data.
Interestingly, however, the author's discussion focused on what they described as "the propensity of blacks to be transplanted at worse performing heart transplant centers". While they rightly conclude that simply shifting patients to higher performing centers would not fully resolve the higher mortality in African Americans, they have totally missed an opportunity to consider deeply what the meaning might be of the most unexpected and thought provoking finding of the study. Worse and perhaps recklessly, the conclusion that the cause of the difference could be attributed to a "propensity", (defined by the Oxford English dictionary as a "natural inclination ") of African Americans to choose more poorly performing centers could actually discourage probing the meaning of their most novel finding. OR 1.42, 95% CI 0.99-2.02, p=0.06). It is startling that the ratio of mortality be betw tw twee e e n n n wh wh whit it ites es e and African Americans at excellently performing centers was worse (0.72) than at poorly pe erf rf for or ormi mi ming ng ng c ce e ente te ers rs rs ( (0.83) (p=0.03 for the differe e enc nc n e e in 1 year mo ort rt r alit ity y y b b between races at ex xce e cellent cent ter ers s s, T T Tab ab ble le 3 3 3) ). ). T T The h hey y co co corr rre e ect t tly id id de e entif fy fy t the e l li im imit it i a at tio ion n ns of f an an na al lys ys si is is o of f li li limi mi mite ted d r re regi gi gist t tr ry da data ta ta. .
Interes es sti ti ting ng ngly ly ly, , ho ho howe we eve ve ver, r r t t the he he a a aut u u ho ho hor' r r s s di di disc sc scus us u si si s on on o f f foc oc ocus us used ed ed o o on n wh wh what at at t t the he hey y y de de desc sc scri ri ribe be bed d as "the At first glance, this is a paper that adds modestly to a longstanding literature enumerating racial/ethnic variation, frequently exclusively described as "racial/ ethnic disparities" in the outcomes of solid organ transplantation, and confirms significantly poorer outcomes in African
Americans than in other demographic groups in the US. 2, 3, 4 However, upon further consideration, the paper highlights a more overarching contemporary issue in medicine that requires critical attention. That is how we conceptualize and, importantly, use language to describe variation among population groups. Because words carry both denotative and connotative meanings, the linguistics of population group differences will be highly influential as we advance the research and clinical care initiatives to personalize medical care.
"Health disparities" according to the Institute of Medicine Report "Unequal Treatment:
Confronting Racial and Ethnic Disparities in Healthcare" are "differences … that are the result of the operation of healthcare systems, legal and regulatory climate as well as discriminatory biases, stereotyping and uncertainty". 5 Thus in this instance, the greater use by African Americans of more poorly performing centers may, in fact, be an example of a true racial disparity driven by the social and system complexities that determine choices of residence, economics of access beyond income level and insurance type, healthcare system services to segments of the population, as well as the nature of the physician patient interaction. A sample of the significant literature exploring these factors 6, 7, 8, 9, 10, 11, 12, 13 might have informed the discussion. The conclusion that the reason for this finding is a "propensity of blacks to be transplanted at poorer performing sites" would suggest that this is a "natural inclination" of this population group. This linguistic frame discourages study of the complex reasons, well beyond what could be described as a "natural inclination", why African Americans might choose such centers. Further, it shifts the blame for use of poorer centers to patients with limited choices as opposed to understanding "Health disparities" according to the Institute of Medicine Report "Uneq qu u ual l Tr Tr rea ea eatm tm tmen en e t t:
Confronting Racial and Ethnic Disparities in Healthcare" are "differences … that are the result o h he e op op ope er erat at atio io ion n of f h h he ea ealthcare systems, legal and reg eg egul ulatory climate as a a w wel el ell l l as a discriminatory biases t ter r reo e typing a and nd nd u u unc nce er rta a ain in inty ty ty". ". ". In contrast to racial disparities, is the issue of "racial differences" as determinants of health status and disease. "Racial differences" should be defined as clinical, biologic, genetic or epigenetic factors associated with disease risk, outcome or treatments not caused by social factors that vary in prevalence in population groups. 14,15,16 "Racial differences" are, however, considerably more difficult to discuss because of the social construct that defines race. "Race"
has been the traditional way to describe populations originating from different continents with similar superficial phenotypic characteristics. Social scientists correctly point out that there is only one human race and that the traditional concept of "race" is used in sociopolitical and economic contexts as a measure of overall difference, superiority and inferiority. Consequently, it is used as a rationale to devalue, demean, and debase specific population groups. It is this meaning of "race" that has been used historically by societies, individuals and sadly even, at times the medical establishment (in a time not distant enough to be erased from the memories of still living African Americans), to justify abuses, legalized crimes and atrocities. Within this context, social scientists rightly insist that the concept of "race" has no place in medicine.
However, we are still left with "differences" sorting along traditionally defined "racial" population groups that have important impact on disease etiology, expression and treatment.
Kilic et al. 1 describe some of these differences in the clinical characteristics and immunologic features that sort along the boundaries of traditionally defined racial groups in their study. These differences require focused study to understand their causes, impact and mitigation. In this has been the traditional way to describe populations originating from different co co ont ntin in i en en nts ts ts w w wit it ith h imilar superficial phenotypic characteristics. Social scientists correctly point out that there is on nly ly ly o o on ne ne h h hum um uman n r r ra ac ace and that the traditional con n nce ce c p p pt of "race" is us u u ed d i i in n n so s ciopolitical and ec con n onomic con nte tex x xts s s as as a a m m mea ea easu su sur re re o o of f f o ov over era all d d dif f ffere en nc ce, s su up upe er rio io ori rit ty y a and nd d i i inf f fer erio io ior ri rity ty. . Co Co Cons ns seue uen nt n l ly ly, instance, "race" is important in medicine, but we are at a loss for a language about race that is unencumbered by and uncoupled from the shameful social history of "race".
Personalized medicine has as its goal use of genetic data providing clues to specific disease risk, expression and therapeutic targets to optimize treatment for every individual, regardless of his/her "social race or ethnicity". One excellent byproduct of this approach effort will be the ability to transcend concepts of race in medicine by the use of knowledge derived from extensive genomic analyses from large numbers of population groups applied to understanding and treating diseases in individuals.
Data will likely, at least initially, still be collected from groups defined by the conventional "racial" groupings, a prospect that generates substantial angst among minority populations who fear that "social racism" may pervade the study of genetic differences and result in "genetic racism".
As this work moves forward, it is perhaps timely to strongly consider finding a language that permits definition of population "differences" without the stigma associated with the social construct of race, but a language that maintains the social construct of race where it is truly important -as the impetus for the very real health "disparities" that stubbornly persist in our society.
One final thought about the most compelling data point in the paper by Kilic et al 1 , the fact that the "racial difference" in outcomes at the excellently performing centers was greater than at the poorly performing centers. The reasons for this finding should strongly drive further aggressive research in both "racial disparities" (i.e. could social factors still strongly influence care at excellent centers resulting in adverse outcomes for African Americans?) and "racial differences" (i.e. how do the biologic, immunologic or genetic factors drive the outcome conventional "racial" groupings, a prospect that generates substantial angst amo on ng ng m m min in nor r orit it ity y y populations who fear that "social racism" may pervade the study of genetic differences and resul f n n " "ge ge gen ne neti ti tic c c ra ra acism sm m" ". ".
As this s w w work rk m m mov ov ves es es f f for or orwa wa ard rd rd, i it t i is s pe erh rh haps ti im me el ly y y to to st tr tron on ngl gly y co co ons s sid de er er f fin indi di ding ng g a a lan an angu gu ua ag age h hat at at p p per er ermi mits ts ts d d def efi in nit it tio ion n n o of f p pop p pul ul lat at atio io ion n n "d "d dif f ffe fe fere re renc nc nces es e " " " w w wit th thou ou out t t th th he e e st st tig ig igma ma m a a ass s soc oci i iat at ted ed e w w wi it ith t th the e e so so oci cial al a construct of r rac ac ace, e, e b b but ut u a a a l l lan n ngu gu guag ag a e e e th th t at at at m m mai ai aint nt ntai ai a ns ns ns th th he e e so so s ci i ial al al c c con on onst st stru ru ruct t t o o of f f r r rac ac ace e e wh wh wher er ere e e it it it i i is s truly f f f differences and are there as yet undefined factors) as well as interactions between disparities and differences. However, if we do not rigorously attend to the conceptual, contextual and linguistic challenges of "race" in medicine, we will remain mired in past centuries and sabotage the future of individually optimized medical care.
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